HSP27 Expression and Survival in Intrahepatic Cholangiocarcinoma
Author Information
Author(s): Romani Antonello A, Crafa Pellegrino, Desenzani Silvia, Graiani Gallia, Lagrasta Costanza, Sianesi Mario, Soliani Paolo, Borghetti Angelo F
Primary Institution: Università degli Studi di Parma
Hypothesis
The expressions of HSP27 and HSP72 are potential prognostic factors in intrahepatic cholangiocarcinoma (IHCCA).
Conclusion
HSP27 expression is associated with aggressive tumor behavior and significantly worsens median overall survival in patients with IHCCA.
Supporting Evidence
- HSP27 expression was significantly associated with cell proliferation.
- Patients with HSP27 expression had a median survival of 11 months compared to over 55 months for those without.
- The presence of HSP72 did not significantly affect overall survival.
Takeaway
This study found that a protein called HSP27 can help doctors understand how serious a patient's liver cancer is, as higher levels of HSP27 mean the patient might not live as long.
Methodology
Immunohistochemical analysis of paraffin-embedded samples from 31 patients with IHCCA, assessing HSP27 and HSP72 expression and correlating with clinical outcomes.
Limitations
The study has a small sample size, which limits the ability to draw broader conclusions.
Participant Demographics
The cohort included 20 females and 11 males, with an average age of 68 years.
Statistical Information
P-Value
0.0003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website